CTOR |
CITIUS ONCOLOGY, INC. |
Dec 12, 2024 |
1 |
$0 |
4 |
Dec 16, 2024 |
Chief Executive Officer, Director |
CTXR |
Citius Pharmaceuticals, Inc. |
Nov 7, 2024 |
1 |
$0 |
4 |
Nov 12, 2024 |
Chief Executive Officer, Director, 10%+ Owner |
CTXR |
Citius Pharmaceuticals, Inc. |
Aug 14, 2024 |
4 |
$0 |
4 |
Sep 27, 2024 |
Chief Executive Officer, Director, 10%+ Owner |
CTOR |
CITIUS ONCOLOGY, INC. |
Aug 12, 2024 |
1 |
$0 |
4/A |
Aug 30, 2024 |
Chief Executive Officer, Director |
CTOR |
CITIUS ONCOLOGY, INC. |
Aug 12, 2024 |
0 |
$0 |
3 |
Aug 14, 2024 |
Chief Executive Officer, Director |
THAR |
Tharimmune, Inc. |
Aug 9, 2024 |
1 |
$0 |
4 |
Aug 12, 2024 |
Director |
CTXR |
Citius Pharmaceuticals, Inc. |
Apr 3, 2024 |
2 |
$0 |
4 |
Apr 5, 2024 |
Chief Executive Officer, Director, 10%+ Owner |
CTXR |
Citius Pharmaceuticals, Inc. |
Oct 10, 2023 |
1 |
$0 |
4 |
Oct 12, 2023 |
Chief Executive Officer, Director, 10%+ Owner |
THAR |
Tharimmune, Inc. |
Nov 7, 2022 |
1 |
$0 |
4 |
Nov 9, 2023 |
Director |
CTXR |
Citius Pharmaceuticals, Inc. |
Oct 4, 2022 |
0 |
$0 |
4/A |
Nov 15, 2022 |
Executive Chairman, Director, 10%+ Owner |
HILS |
Hillstream BioPharma Inc. |
Mar 21, 2022 |
1 |
$0 |
4 |
Mar 23, 2022 |
Director |
HILS |
Hillstream BioPharma Inc. |
Jan 14, 2022 |
3 |
$116K |
4 |
Jan 18, 2022 |
Director |
HILS |
Hillstream BioPharma Inc. |
Jan 11, 2022 |
0 |
$0 |
3 |
Jan 11, 2022 |
Director |
CTXR |
Citius Pharmaceuticals, Inc. |
Oct 11, 2021 |
1 |
$0 |
4 |
Oct 13, 2021 |
Executive Chairman, Director, 10%+ Owner |
CTXR |
Citius Pharmaceuticals, Inc. |
Jul 22, 2021 |
1 |
$0 |
4 |
Jul 26, 2021 |
Executive Chairman, Director, 10%+ Owner |